Replacing RhodioPrime™ 6X with SalidroPure™ in the Newest Formulation of the Defib Preworkout

SalidroPure™ is the pure form of salidroside, the most researched bioactive compound found in the Rhodiola plant. Rhodiola has a long history of traditional use across Central Asia and Northern Europe, and in modern supplementation it is best known for its adaptogenic properties, supporting mood, stamina, and resilience under stress. Salidroside is the compound responsible for much of that reputation. It plays a broad role in enhancing both physical and mental performance, reducing fatigue, and improving overall well-being, particularly during prolonged periods of high stress.

A core area of salidroside research centres on how it influences the brain's production and maintenance of dopamine and noradrenaline, two neurotransmitters central to motivation, focus, and the ability to push through fatigue. It also helps protect muscles from exercise-induced damage and supports more efficient oxygen utilisation during intense effort.[4][5]

This article covers the science behind salidroside, the human trial data, and why HR Labs has replaced RhodioPrime™ 6X with SalidroPure™ in the newest Defib formulation.

Quick Facts

Main benefit: Supports dopamine and noradrenaline availability by increasing production capacity and slowing enzymatic breakdown. Protects against exercise-induced muscle damage and preserves mood under accumulated training stress.

Research backing: One published randomised, double-blind, placebo-controlled human trial on biosynthetic salidroside (the same production method as SalidroPure™), plus a broad base of pharmacological research on salidroside's CNS and exercise-related mechanisms.

Best for: Athletes in sustained high-volume training blocks where performance, mood, and recovery need to hold up across sessions rather than just within one.

Dosage: 30mg SalidroPure™ per serve in Defib, within the dose range shown effective in the human trial.

Timeline: Acute dopaminergic and noradrenergic effects contribute to each session. Muscle protection and mood resilience benefits build over consistent use, with meaningful separation from placebo observed over 16 days.[5]

Why SalidroPure™ Replaces Traditional Rhodiola Extracts

For the newest Defib reformulation, HR Labs has replaced RhodioPrime™ 6X with SalidroPure™. Both ingredients are developed by NNB Nutrition, but SalidroPure™ represents their continued progression in ingredient innovation, moving toward greater purity, consistency, and a proactive response to the changing regulatory standards for rhodiola. The case for using fermentation-derived salidroside rather than a rhodiola extract comes down to several practical considerations.

Wild Rhodiola Plant Conservation

As of February 2023, the rhodiola genus is CITES-protected. Wild populations in Russia, China, and Central Asia have declined dramatically from overharvesting, and the plant takes anywhere from five to twenty years to reach maturity depending on growing conditions. The existing supply simply cannot keep pace with the sharp increase in demand over the last decade. SalidroPure™ is produced by precision fermentation, providing a sustainable alternative that uses no plant material in the process.[2] The final product is a nature-identical compound, not genetically modified, WADA-compliant, and suitable for vegan diets.[3]

Purity and Consistency

Standard rhodiola extracts contain roughly 1% salidroside, with some more specialised extracts reaching up to 5%. RhodioPrime™ 6X pushed this further with a 6% salidroside yield, which was a meaningful step forward for rhodiola-based ingredients at the time. SalidroPure™, however, is 98.5% pure or higher by HPLC testing. Every batch delivers a known, consistent quantity of the active compound, removing the variability that comes with herbal sourcing through longer and often poorly managed supply chains, a problem made worse by the growing gap between supply and demand.

To put that in practical terms: getting 50 mg of salidroside from a standard 1% rhodiola extract would require 5,000 mg of extract per serve, and that assumes the extract is true to label claim. RhodioPrime™ 6X improved this significantly, requiring approximately 833 mg of extract for the same 50 mg of salidroside. SalidroPure™ takes this a step further, delivering the same compound at roughly 51 mg of material, making it far more viable for capsule, tablet, and beverage formulations like Defib where serve size is a real constraint.

Flavour and Mouthfeel

Rhodiola extracts carry a characteristic bitter taste and an astringent, mouth-drying sensation. The bitterness comes primarily from the phenolic compounds present in the extract, including gallic acid and various flavonoid glycosides. The drying mouthfeel is driven by proanthocyanidins and condensed tannins, which bind to salivary proteins and reduce the lubricating sensation in the mouth. At higher doses this gets more problematic to mask, which limits how much rhodiola extract can be included in a formula before palatability is poor.

Pure salidroside, as delivered by SalidroPure™, inherently has no meaningful flavour or texture impact. This allowed HR Labs to achieve a higher salidroside dose in the upgraded Defib while also improving the overall flavour and texture experience.

How SalidroPure™ Works in the Brain

To understand what salidroside does in a pre-workout context, it helps to look at the brain chemistry behind sustained effort.

Dopamine and noradrenaline are the neurotransmitters that drive motivation, focus, and your capacity to maintain intensity during a session. Your body builds them from the amino acid tyrosine through a chain of enzymatic steps, and breaks them down through enzymes called monoamine oxidases (MAO). How much dopamine and noradrenaline you have available at any given moment depends on the balance between how fast you produce them and how fast you clear them.[1]

Salidroside shifts this balance in your favour through two mechanisms.

First, it increases the activity of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine production. More TH activity means greater capacity to convert available tyrosine into dopamine, raising dopamine and its metabolites in brain regions responsible for motor control and reward.[4]

Second, it slows the breakdown. Salidroside inhibits both MAO-A and MAO-B, the enzymes that degrade dopamine and noradrenaline. The neurotransmitters you produce stick around longer before being cleared.

The practical result is higher availability of the neurotransmitters responsible for drive, focus, and effort tolerance. This is not the same as a stimulant effect. Caffeine and other stimulants increase the release of these chemicals. Salidroside supports the supply chain that produces them and slows the process that removes them. That said, the two mechanisms are complementary, which is exactly why salidroside sits alongside stimulant ingredients in Defib rather than replacing them.

This regulatory effect extends beyond a single session. In the human trial on biosynthetic salidroside, the placebo group showed significant increases in fatigue and total mood disturbance over the study period while the salidroside group maintained stable mood across all domains.[5] For anyone training consistently at high intensity, this resilience under accumulated stress may be just as important as the acute performance support.

The Human Study: Salidroside and Exercise Performance

In 2024 a randomised, double-blind, placebo-controlled trial using biosynthetic salidroside, the same as SalidroPure™, was published in the Journal of the International Society of Sports Nutrition.

The study enrolled 50 healthy, physically active young adults, both male and female. Participants were randomised to receive either 60 mg per day of biosynthetic salidroside or a matched placebo for 16 days. The exercise protocol involved repeated bouts of intense physical testing designed to induce meaningful muscle damage and accumulate fatigue over the supplementation period, specifically to reflect the reality of consistent hard training. It is not just about one session, but about how well performance holds up when sessions stack on top of each other.

When outcomes were evaluated, the salidroside group maintained their exercise performance across the full study duration, while the placebo group showed a measurable decline.

The secondary outcomes reinforced the performance data. At 24 hours post-exercise, the results showed meaningful separation between the groups:

• Myoglobin, a marker of skeletal muscle fibre disruption, increased significantly at 24 hours post-exercise in the placebo group but showed no statistically significant increase in the salidroside group, indicating reduced exercise-induced muscle damage.
• Fatigue-inertia scores on the POMS increased significantly in the placebo group over the study period while the salidroside group reported no change (p = 0.62).
• Friendliness scores declined significantly in the placebo group (p < 0.01, Cohen's d = 0.49) with a trend toward increased total mood disturbance (p = 0.06), while the salidroside group maintained stable mood across all domains.
• The placebo group completed significantly fewer time-to-exhaustion intervals at post-testing compared to baseline (p = 0.03, Cohen's d = 0.39), while the salidroside group's interval count remained virtually identical between time points.
• Overall percent predicted oxygen uptake during high-intensity intermittent exercise was significantly higher in the salidroside group at 82.7 ± 6.9% compared to 79.6 ± 7.0% for placebo (p < 0.01, Cohen's d = 0.45).

The salidroside group showed a consistent advantage across all of these domains. The proposed mechanisms line up well with the preclinical literature: salidroside appears to preserve mitochondrial function under exercise stress, support the body's endogenous antioxidant enzyme systems, and reduce the accumulation of muscle damage markers that build up during intense training blocks. Importantly, the dose used was modest at 60 mg per day, meaning meaningful effects can be achieved in the scope of dosing used in Defib, especially when considering it is paired alongside other dopaminergic ingredients.

SalidroPure™ in the Defib Preworkout

Defib, available in New Zealand through Strom Sports, includes SalidroPure™ at 30mg per serve. The dose sits within the range shown to preserve exercise performance, reduce muscle damage, and maintain mood state in the human trial using biosynthetic salidroside, the same production method behind SalidroPure™.

SalidroPure™ works alongside the other dopamine-targeting ingredients in the Defib formula. Each addresses a different part of the same system:

• Caffeine forces greater dopamine release and blocks fatigue signalling.
• Sabroxy® slows dopamine clearance and reduces the GABAergic brake on cognition.
• SalidroPure™ increases the rate-limiting enzyme for dopamine production and slows breakdown through MAO inhibition.

Together, these cover production capacity, release, clearance, and breakdown. SalidroPure™ also adds a dimension the others do not: protection against the cumulative physical effects of hard training. The reduction in muscle damage markers and preserved exercise capacity across repeated sessions is unique to salidroside in this formula, and reflects its dual role as both a neurochemical and physical performance support.

The shift from RhodioPrime™ 6X to SalidroPure™ gives a purer, more consistent, and more sustainable version of the same active compound, at a dose that fits within the formula without the flavour and serve-size compromises that come with traditional rhodiola extracts.

For the full breakdown of how SalidroPure™ works alongside caffeine, Sabroxy®, and the rest of the Defib formula, see the Defib article.

For the science behind Sabroxy® and how its DAT inhibition complements SalidroPure™'s MAO inhibition, see the Sabroxy® article.

Frequently Asked Questions

How quickly will I notice SalidroPure™?

The dopamine and noradrenaline support is an acute mechanism, so the motivational and focus effects contribute to the session you take it for. The protective effects on muscle damage and mood resilience build over consistent use, with the human trial showing meaningful separation from placebo over 16 days of daily dosing.

Is this the same as taking rhodiola?

SalidroPure™ delivers the same primary active compound found in rhodiola (salidroside) but at 98.5%+ purity compared to 1-6% in typical rhodiola extracts. You are getting a known, consistent dose of the compound that drives the benefits, without the variability, taste issues, or sustainability concerns of plant-sourced extracts. Whole rhodiola extracts do include other bioactive that will contribute to different effects also, such as the well known rosavins.

Why replace RhodioPrime™ 6X if it was already working?

RhodioPrime™ 6X was a good ingredient at the time. SalidroPure™ is the same active compound delivered more purely, more consistently, and more sustainably. It also allows a higher effective salidroside dose to be achieved without the serve-size and flavour trade-offs that come with herbal extracts.

Does SalidroPure™ overlap with Sabroxy®?

Both support the dopaminergic system, but through different mechanisms. SalidroPure™ increases production capacity and slows enzymatic breakdown (MAO inhibition). Sabroxy® slows transporter-mediated clearance (DAT inhibition) and reduces GABAergic inhibition. They are complementary rather than redundant, which is why both are in the formula.

Is it safe for drug-tested athletes?

SalidroPure™ is WADA-compliant and not prohibited by any major athletic body. Always verify against your specific organisation's banned substance list.

Shop DEFIB™ Pre-Workout here

MADE FOR PROGRESS

References

1. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481-493.
2. CITES. CoP19 Prop. 45: Inclusion of Rhodiola spp. in Appendix II. Convention on International Trade in Endangered Species of Wild Fauna and Flora; November 2022. Available at: https://cites.org/sites/default/files/documents/E-CoP19-Prop-45.pdf
3. NNB Nutrition. SalidroPure™ product specification sheet. NutriScience Innovations, 2024.
4. Zhong Z, Han J, Zhang J, Xiao Q, Hu J, Chen L. Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system. Drug Des Devel Ther. 2018;12:1479-1489.
5. Sas-Nowosielska H, Magiera A, Sas-Nowosielski K, et al. Effects of short-term biosynthetic salidroside supplementation on exercise performance, mood state, and markers of inflammation and muscle damage in healthy active young adults. J Int Soc Sports Nutr. 2024;21(1):2396890.

FOUND THIS HELPFUL?

This content is for educational purposes only and does not intend to cure or diagnose disease, nor make any health claims. There is no intent to slander in any way, but rather produce an informed and accurate third party perspective on the product. Always consult your accredited medical professional before introducing a new supplement. This content is not to be copied or repurposed in any form without express permission from the author.

First published for HRLABS.co.uk 23rd January 2026